Key result
Transcatheter mitral valve repair and replacement devices show early potential to safely treat high-risk patients with functional mitral regurgitation who are not candidates for traditional surgery.
Transcatheter mitral interventions offer a potential therapeutic option for high-risk patients with secondary mitral regurgitation who are ineligible for surgery.
Mitral regurgitation is considered the most prevalent valve disease in the United States and its incidence is increasing due to the aging population. Surgical mitral valve repair and replacement are effective at reducing regurgitation due to ischemia, but many patients with secondary mitral regurgitation do not undergo surgery because they are too high risk. Transcatheter devices that mimic surgical techniques are rapidly being developed to reduce the risks traditionally associated with surgical mitral valve repair and replacement. Despite the challenges posed by complex anatomy and multiple etiologies of mitral valve pathology, early results of transcatheter mitral repair and replacement indicate that they have the potential to increase the number of patients with secondary MR who are candidates for intervention.
No takes yet. Share an insight, caveat, or question.
Chancellor et al. (2018) conducted a review in Functional mitral regurgitation. Transcatheter mitral valve interventions was evaluated. Transcatheter mitral valve repair and replacement devices show early potential to safely treat high-risk patients with functional mitral regurgitation who are not candidates for traditional surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: